RBM39 and leukemia: To the best of our knowledge, MGMT has not been identified as a direct splicing target of RBM39 in RNA-seq or proteomic analyses from neuroblastoma and leukemia models, which include large-scale RBM39 degrader transcriptomes cataloging numerous high-confidence splicing targets [34,39].